IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $68,175 | -74.1% | 10,669 | -32.3% | 0.00% | -100.0% |
| Q1 2022 | $263,000 | -69.2% | 15,768 | -41.6% | 0.00% | -50.0% |
| Q1 2021 | $855,000 | -40.5% | 27,017 | -12.7% | 0.00% | -33.3% |
| Q4 2020 | $1,437,000 | +166.6% | 30,965 | +89.2% | 0.00% | +200.0% |
| Q3 2020 | $539,000 | +19.8% | 16,368 | -0.2% | 0.00% | 0.0% |
| Q2 2020 | $450,000 | +11150.0% | 16,397 | +10831.3% | 0.00% | – |
| Q4 2019 | $4,000 | -99.5% | 150 | -99.7% | 0.00% | -100.0% |
| Q3 2019 | $809,000 | -90.4% | 44,427 | -87.0% | 0.00% | -90.0% |
| Q2 2019 | $8,408,000 | +210100.0% | 342,883 | +74117.1% | 0.02% | – |
| Q1 2019 | $4,000 | 0.0% | 462 | -8.5% | 0.00% | – |
| Q4 2018 | $4,000 | -98.9% | 505 | -98.4% | 0.00% | -100.0% |
| Q3 2018 | $360,000 | -68.7% | 32,000 | -64.4% | 0.00% | -66.7% |
| Q2 2018 | $1,151,000 | +2.8% | 89,911 | +35.7% | 0.00% | 0.0% |
| Q1 2018 | $1,120,000 | +27900.0% | 66,252 | +14209.3% | 0.00% | – |
| Q4 2017 | $4,000 | – | 463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |